RecallDepth
Class II Ongoing

Gabapentin Capsules, USP, 100 mg, 10 Capsules (10 x 1 blister pack), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, USA, NDC 0904-6665-61 (Blister pack), NDC 55154-3363-0 (Outer Bag).

This recall is currently active, issued October 29, 2025. It was issued by The Harvard Drug Group Llc.

Company
The Harvard Drug Group Llc
Recall Initiated
October 10, 2025
Posted
October 29, 2025
Recall Number
D-0031-2026
Voluntary / Mandated
Voluntary: Firm initiated
Firm Location
Dublin, OH, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity .

Distribution

US Nationwide.

Lot / Code Info

Lot # M04989A [Bag], M04989 [Blister Pack], Exp Date: 02/2026; Lot # M05056A [Bag], M05056 [Blister Pack], Exp Date: 04/2026; Lot # M05150A [Bag], M05150 [Blister Pack], Exp Date: 07/2026; Lot # M05312A [Bag], M05312 [Blister Pack], and M05342A [Bag], M05342 [Blister Pack], Exp Date: 01/2027.

More recalls by The Harvard Drug Group Llc

View all recalls by this company →

Other recent Class II Drug recalls